{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:01:55Z","timestamp":1789639315677,"version":"4.0.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-026-02095-z","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:02:39Z","timestamp":1783400559000},"page":"3909-3950","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In Vitro and In Silico Assessment of Anticancer Activity of Venom-Derived and Biomimetic Neurotransmitter Inhibitor Pentapeptides"],"prefix":"10.1007","volume":"84","author":[{"given":"Dilan","family":"Akhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilge","family":"Bicak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Akman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serda","family":"Kecel Gunduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"3","key":"2095_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/scientificamerican0996-62","volume":"275","author":"RA Weinberg","year":"1996","unstructured":"Weinberg, R. A. (1996). How cancer arises. Scientific American, 275(3), 62\u201370.","journal-title":"Scientific American"},{"issue":"3-4","key":"2095_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/jnci\/88.3-4.183","volume":"88","author":"EA Zang","year":"1996","unstructured":"Zang, E. A., & Wynder, E. L. (1996). Differences in lung cancer risk between men and women: examination of the evidence. JNCI: Journal of the National Cancer Institute, 88(3-4), 183\u2013192.","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"4","key":"2095_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1210\/edrv.19.4.0337","volume":"19","author":"C Lo\u0301pez-Oti\u0301n","year":"1998","unstructured":"Lo\u0301pez-Oti\u0301n, C., & Diamandis, E. P. (1998). Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocrine Reviews, 19(4), 365\u2013396.","journal-title":"Endocrine Reviews"},{"issue":"4","key":"2095_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/1756283X13478680","volume":"6","author":"PE Oberstein","year":"2013","unstructured":"Oberstein, P. E., & Olive, K. P. (2013). Pancreatic cancer: why is it so hard to treat? Therapeutic Advances in Gastroenterology, 6(4), 321\u2013337.","journal-title":"Therapeutic Advances in Gastroenterology"},{"key":"2095_CR5","first-page":"1","volume-title":"Paclitaxel","author":"MS Chandraprasad","year":"2022","unstructured":"Chandraprasad, M. S., Dey, A., & Swamy, M. K. (2022). Introduction to cancer and treatment approaches. Paclitaxel (pp. 1\u201327. Elsevier."},{"key":"2095_CR6","doi-asserted-by":"crossref","unstructured":"Feng, C., Tan P., Nie G. & Zhu M. Biomimetic and bioinspired nano\u2010platforms for cancer vaccine development. in Exploration. 2023. Wiley Online Library.","DOI":"10.1002\/EXP.20210263"},{"issue":"7","key":"2095_CR7","first-page":"3565","volume":"36","author":"Y Mine","year":"2016","unstructured":"Mine, Y., Munir, H., Nakanishi, Y., & Sugiyama, D. (2016). Biomimetic peptides for the treatment of cancer. Anticancer Research, 36(7), 3565\u20133570.","journal-title":"Anticancer Research"},{"issue":"1","key":"2095_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-017-0328-x","volume":"24","author":"S Marqus","year":"2017","unstructured":"Marqus, S., Pirogova, E., & Piva, T. J. (2017). Evaluation of the use of therapeutic peptides for cancer treatment. Journal of biomedical Science, 24(1), 21.","journal-title":"Journal of biomedical Science"},{"key":"2095_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coph.2019.01.008","volume":"47","author":"K Kurrikoff","year":"2019","unstructured":"Kurrikoff, K., Aphkhazava, D., & Langel, \u00dc. (2019). The future of peptides in cancer treatment. Current Opinion in Pharmacology, 47, 27\u201332.","journal-title":"Current Opinion in Pharmacology"},{"key":"2095_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/neuonc\/now212.047","volume":"18","author":"D Miller","year":"2016","unstructured":"Miller, D., Patil, C., Walker, D., Kittle, D., Nufer, K., Yamada, M., Butte, P., Prow, T., Novak, J., Black, K., & Mamelak, A. (2016). Phase 1 safety study of blz-100 for fluorescence-guided resection of glioma in adult subjects. Neuro-Oncology, 18, 12\u201313.","journal-title":"Neuro-Oncology"},{"issue":"2","key":"2095_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1517\/17425247.4.2.175","volume":"4","author":"AN Mamelak","year":"2007","unstructured":"Mamelak, A. N., & Jacoby, D. B. (2007). Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opinion on Drug Delivery, 4(2), 175\u2013186.","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"9","key":"2095_CR12","first-page":"10","volume":"1","author":"X Wu","year":"2010","unstructured":"Wu, X., Jian, X., Yin, B., & He, Z. (2010). Development of the research on the application of chlorotoxin in imaging diagnostics and targeted therapies for tumors. Membranes, 1(9), 10\u201311.","journal-title":"Membranes"},{"issue":"1","key":"2095_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-11-6","volume":"11","author":"V Asher","year":"2011","unstructured":"Asher, V., Warren, A., Shaw, R., Sowter, H., Bali, A., & Khan, R. (2011). The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line. Cancer Cell International, 11(1), 6.","journal-title":"Cancer Cell International"},{"issue":"9","key":"2095_CR14","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1002\/jcb.23166","volume":"112","author":"Y Zhao","year":"2011","unstructured":"Zhao, Y., Cai, X., Ye, T., Huo, J., Liu, C., Zhang, S., & Cao, P. (2011). Analgesic\u2010antitumor peptide inhibits proliferation and migration of SHG\u201044 human malignant glioma cells. Journal of Cellular Biochemistry, 112(9), 2424\u20132434.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"2","key":"2095_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3892\/ol.2012.1049","volume":"5","author":"Y Gu","year":"2013","unstructured":"Gu, Y., Liu, S.-L., Ju, W.-Z., Li, C.-Y., & Cao, P. (2013). Analgesic-antitumor peptide induces apoptosis and inhibits the proliferation of SW480 human colon cancer cells. Oncology Letters, 5(2), 483\u2013488.","journal-title":"Oncology Letters"},{"issue":"1","key":"2095_CR16","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.bone.2010.10.127","volume":"48","author":"P Cl\u00e9ment-Lacroix","year":"2011","unstructured":"Cl\u00e9ment-Lacroix, P., Berrocal, E., Heckmann, B., Wigerinck, P., Lorenzon, G., & Pujuguet, P. (2011). GLPG0187 inhibits progression of established bone metastasis and achieves maximum efficacy when combined with standard-of-care metastatic breast cancer treatments. Bone, 48(1), S45.","journal-title":"Bone"},{"issue":"19","key":"2095_CR17","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1158\/1078-0432.CCR-12-3490","volume":"19","author":"E K\u00e4hk\u00f6nen","year":"2013","unstructured":"K\u00e4hk\u00f6nen, E., Jambor, I., Kemppainen, J., Lehti\u00f6, K., Gr\u00f6nroos, T. J., Kuisma, A., Luoto, P., Sipil\u00e4, H. J., Tolvanen, T., & Alanen, K. (2013). In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548. Clinical Cancer Research, 19(19), 5434\u20135443.","journal-title":"Clinical Cancer Research"},{"issue":"59","key":"2095_CR18","doi-asserted-by":"publisher","first-page":"100908","DOI":"10.18632\/oncotarget.21740","volume":"8","author":"R Ma","year":"2017","unstructured":"Ma, R., Mahadevappa, R., & Kwok, H. F. (2017). Venom-based peptide therapy: insights into anti-cancer mechanism. Oncotarget, 8(59), 100908.","journal-title":"Oncotarget"},{"key":"2095_CR19","first-page":"555945","volume":"16","author":"RK Upadhyay","year":"2018","unstructured":"Upadhyay, R. K. (2018). Use of animal venom peptides\/toxins in cancer. Curr Trends Biomedical Eng & Biosci, 16, 555945.","journal-title":"Curr Trends Biomedical Eng & Biosci"},{"key":"2095_CR20","doi-asserted-by":"publisher","DOI":"10.1039\/9781849737876","volume-title":"Venoms to drugs: venom as a source for the development of human therapeutics","author":"G King","year":"2015","unstructured":"King, G. (2015). Venoms to drugs: venom as a source for the development of human therapeutics. (Royal Society of Chemistry."},{"issue":"3","key":"2095_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41388-019-1006-0","volume":"39","author":"S-H Jiang","year":"2020","unstructured":"Jiang, S.-H., Hu, L.-P., Wang, X., Li, J., & Zhang, Z.-G. (2020). Neurotransmitters: emerging targets in cancer. Oncogene, 39(3), 503\u2013515.","journal-title":"Oncogene"},{"issue":"1","key":"2095_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano, A., Foo, A. S., Lam, H. Y., Yap, K. C., Jacot, W., Jones, R. H., Eng, H., Nair, M. G., Makvandi, P., & Geoerger, B. (2023). PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Molecular cancer, 22(1), 138.","journal-title":"Molecular cancer"},{"issue":"1","key":"2095_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-pathol-011110-130206","volume":"6","author":"G da Cunha Santos","year":"2011","unstructured":"da Cunha Santos, G., Shepherd, F. A., & Tsao, M. S. (2011). EGFR mutations and lung cancer. Annual Review of Pathology: Mechanisms of Disease, 6(1), 49\u201369.","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"issue":"3","key":"2095_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/jcb.10661","volume":"91","author":"A Ghosh","year":"2004","unstructured":"Ghosh, A., & Heston, W. D. (2004). Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. Journal of Cellular Biochemistry, 91(3), 528\u2013539.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"8","key":"2095_CR25","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2174\/156800961508151001105814","volume":"15","author":"E V Broude","year":"2015","unstructured":"V Broude, E., Gyorffy, B., Chumanevich, A. A., Chen, M., McDermott, M. S. J., Shtutman, M., Catroppo, J. F., & Roninson, I. B. (2015). Expression of CDK8 and CDK8-interacting genes as potential biomarkers in breast cancer. Current Cancer Drug Targets, 15(8), 739\u2013749.","journal-title":"Current Cancer Drug Targets"},{"issue":"4","key":"2095_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S1471-4892(03)00071-7","volume":"3","author":"S Huang","year":"2003","unstructured":"Huang, S., & Houghton, P. J. (2003). Targeting mTOR signaling for cancer therapy. Current Opinion in Pharmacology, 3(4), 371\u2013377.","journal-title":"Current Opinion in Pharmacology"},{"key":"2095_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","volume":"698","author":"S Noorolyai","year":"2019","unstructured":"Noorolyai, S., Shajari, N., Baghbani, E., Sadreddini, S., & Baradaran, B. (2019). The relation between PI3K\/AKT signalling pathway and cancer. Gene, 698, 120\u2013128.","journal-title":"Gene"},{"issue":"1","key":"2095_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/156800908783497140","volume":"8","author":"E Tokunaga","year":"2008","unstructured":"Tokunaga, E., Oki, E., Egashira, A., Sadanaga, N., Morita, M., Kakeji, Y., & Maehara, Y. (2008). Deregulation of the Akt pathway in human cancer. Current Cancer Drug Targets, 8(1), 27\u201336.","journal-title":"Current Cancer Drug Targets"},{"issue":"6","key":"2095_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4172\/1948-5956.1000408","volume":"8","author":"B Geleta","year":"2016","unstructured":"Geleta, B., Makonnen, E., & Abay, S. (2016). Cyclic dependent kinase (CDK): role in cancer pathogenesis and as drug target in cancer therapeutics. J Cancer Sci Ther, 8(6), 160\u2013167.","journal-title":"J Cancer Sci Ther"},{"issue":"2","key":"2095_CR30","first-page":"1024","volume":"4","author":"S Agarwal","year":"2016","unstructured":"Agarwal, S., & Mehrotra, R. (2016). An overview of molecular docking. JSM Chem, 4(2), 1024\u20131028.","journal-title":"JSM Chem"},{"issue":"6294","key":"2095_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/347631a0","volume":"347","author":"M Karplus","year":"1990","unstructured":"Karplus, M., & Petsko, G. A. (1990). Molecular dynamics simulations in biology. Nature, 347(6294), 631\u2013639.","journal-title":"Nature"},{"issue":"1","key":"2095_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0165-6147(00)01584-4","volume":"22","author":"GC Terstappen","year":"2001","unstructured":"Terstappen, G. C., & Reggiani, A. (2001). In silico research in drug discovery. Trends in Pharmacological Sciences, 22(1), 23\u201326.","journal-title":"Trends in Pharmacological Sciences"},{"key":"2095_CR33","unstructured":"Frisch, M., Trucks G., Schlegel H., Scuseria G., Robb M., Cheeseman J., Scalmani G., Barone V., Petersson G. & Nakatsuji H., Gaussian 16 Revision A. 03, 2016. Gaussian Inc. Wallingford CT, 2016. 1(2): p. 3."},{"issue":"3","key":"2095_CR34","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1063\/1.462066","volume":"96","author":"AD Becke","year":"1992","unstructured":"Becke, A. D. (1992). Density\u2010functional thermochemistry. I. The effect of the exchange\u2010only gradient correction. The. Journal of Chemical Physics, 96(3), 2155\u20132160.","journal-title":"Journal of Chemical Physics"},{"key":"2095_CR35","unstructured":"Maestro, Schr\u00f6dinger, LLC, New York, NY, 2020-4, 2020."},{"issue":"45","key":"2095_CR36","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996). Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. Journal of the American Chemical Society, 118(45), 11225\u201311236.","journal-title":"Journal of the American Chemical Society"},{"issue":"6","key":"2095_CR37","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1021\/ja00214a001","volume":"110","author":"WL Jorgensen","year":"1988","unstructured":"Jorgensen, W. L., & Tirado-Rives, J. (1988). The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. Journal of the American Chemical Society, 110(6), 1657\u20131666.","journal-title":"Journal of the American Chemical Society"},{"issue":"5","key":"2095_CR38","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1021\/ct900587b","volume":"6","author":"D Shivakumar","year":"2010","unstructured":"Shivakumar, D., Williams, J., Wu, Y., Damm, W., Shelley, J., & Sherman, W. (2010). Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field. Journal of Chemical Theory and Computation, 6(5), 1509\u20131519.","journal-title":"Journal of Chemical Theory and Computation"},{"issue":"2","key":"2095_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1021\/ml300327z","volume":"4","author":"S Sogabe","year":"2013","unstructured":"Sogabe, S., Kawakita, Y., Igaki, S., Iwata, H., Miki, H., Cary, D. R., Takagi, T., Takagi, S., Ohta, Y., & Ishikawa, T. (2013). Structure-based approach for the discovery of pyrrolo [3, 2-d] pyrimidine-based EGFR T790M\/L858R mutant inhibitors. ACS Medicinal Chemistry Letters, 4(2), 201\u2013205.","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"4","key":"2095_CR40","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S1097-2765(05)00089-4","volume":"6","author":"EH Walker","year":"2000","unstructured":"Walker, E. H., Pacold, M. E., Perisic, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000). Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Molecular Cell, 6(4), 909\u2013919.","journal-title":"Molecular Cell"},{"issue":"7448","key":"2095_CR41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature12122","volume":"497","author":"H Yang","year":"2013","unstructured":"Yang, H., Rudge, D. G., Koos, J. D., Vaidialingam, B., Yang, H. J., & Pavletich, N. P. (2013). mTOR kinase structure, mechanism and regulation. Nature, 497(7448), 217\u2013223.","journal-title":"Nature"},{"issue":"36","key":"2095_CR42","doi-asserted-by":"publisher","first-page":"12711","DOI":"10.1021\/ja104591m","volume":"132","author":"AX Zhang","year":"2010","unstructured":"Zhang, A. X., Murelli, R. P., Barinka, C., Michel, J., Cocleaza, A., Jorgensen, W. L., Lubkowski, J., & Spiegel, D. A. (2010). A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules. Journal of the American Chemical Society, 132(36), 12711\u201312716.","journal-title":"Journal of the American Chemical Society"},{"issue":"6","key":"2095_CR43","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1073\/pnas.1917635117","volume":"117","author":"F Klatt","year":"2020","unstructured":"Klatt, F., Leitner, A., Kim, I. V., Ho-Xuan, H., Schneider, E. V., Langhammer, F., Weinmann, R., M\u00fcller, M. R., Huber, R., & Meister, G. (2020). A precisely positioned MED12 activation helix stimulates CDK8 kinase activity. Proceedings of the National Academy of Sciences, 117(6), 2894\u20132905.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"2095_CR44","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MH Olsson","year":"2011","unstructured":"Olsson, M. H., S\u00f8ndergaard, C. R., Rostkowski, M., & Jensen, J. H. (2011). PROPKA3: consistent treatment of internal and surface residues in empirical p K a predictions. Journal of Chemical Theory and Computation, 7(2), 525\u2013537.","journal-title":"Journal of Chemical Theory and Computation"},{"issue":"1","key":"2095_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2016","unstructured":"Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., & Knight, J. L. (2016). OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281\u2013296.","journal-title":"Journal of Chemical Theory and Computation"},{"issue":"1","key":"2095_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1021\/ci300425v","volume":"53","author":"PA Greenidge","year":"2013","unstructured":"Greenidge, P. A., Kramer, C., Mozziconacci, J.-C., & Wolf, R. M. (2013). MM\/GBSA binding energy prediction on the PDBbind data set: successes, failures, and directions for further improvement. Journal of Chemical Information and Modeling, 53(1), 201\u2013209.","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"5","key":"2095_CR47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S., & Ryde, U. (2015). The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449\u2013461.","journal-title":"Expert Opinion on Drug Discovery"},{"issue":"2","key":"2095_CR48","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J., Honig, B., Shaw, D. E., & Friesner, R. A. (2004). A hierarchical approach to all\u2010atom protein loop prediction. Proteins: Structure, Function, and Bioinformatics, 55(2), 351\u2013367.","journal-title":"Proteins: Structure, Function, and Bioinformatics"},{"issue":"3","key":"2095_CR49","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","volume":"320","author":"MP Jacobson","year":"2002","unstructured":"Jacobson, M. P., Friesner, R. A., Xiang, Z., & Honig, B. (2002). On the role of the crystal environment in determining protein side-chain conformations. Journal of molecular biology, 320(3), 597\u2013608.","journal-title":"Journal of molecular biology"},{"key":"2095_CR50","doi-asserted-by":"crossref","unstructured":"Bowers, K. J., Chow, E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., ... & Shaw, D. E. (2006, November). Scalable algorithms for molecular dynamics simulations on commodity clusters. In Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing (pp. 84-es).","DOI":"10.1145\/1188455.1188544"},{"issue":"2","key":"2095_CR51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1517\/17460441.2012.648612","volume":"7","author":"WP Walters","year":"2012","unstructured":"Walters, W. P. (2012). Going further than Lipinski\u2019s rule in drug design. Expert Opinion on Drug Discovery, 7(2), 99\u2013107.","journal-title":"Expert Opinion on Drug Discovery"},{"issue":"2","key":"2095_CR52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.55691\/2278-344X.1029","volume":"11","author":"SS Bhat","year":"2022","unstructured":"Bhat, S. S., Pradeep, S., Jadhav, G., Devegowda, D., Sommano, S. R., Shivamallu, C., Kollur, S. P., & Prasad, S. K. (2022). In silico examination of peptides containing selenium and ebselen backbone to assess their tumoricidal potential. International Journal of Health & Allied Sciences, 11(2), 215\u2013222.","journal-title":"International Journal of Health & Allied Sciences"},{"issue":"1","key":"2095_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.25026\/jtpc.v7i1.432","volume":"7","author":"A Yuliana","year":"2023","unstructured":"Yuliana, A., Rahmiyani, I., & Kartika, C. (2023). Molecular docking and molecular dynamics simulation using Monascus sp. as a candidate cervical cancer drug. Journal of Tropical Pharmacy and Chemistry, 7(1), 41\u201351.","journal-title":"Journal of Tropical Pharmacy and Chemistry"},{"key":"2095_CR54","doi-asserted-by":"publisher","first-page":"1221275","DOI":"10.3389\/fonc.2023.1221275","volume":"13","author":"P Reddy","year":"2023","unstructured":"Reddy, P., Pradeep, S., Dharmashekar, C., MR, S. C., Srinivasa, C., Shati, A. A., Alfaifi, M. Y., Elbehairi, S. E. I., Achar, R. R., & Silina, E. (2023). Cell cycle arrest and apoptotic studies of Terminalia chebula against MCF-7 breast cancer cell line: an in vitro and in silico approach. Frontiers in Oncology, 13, 1221275.","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"2095_CR55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.55691\/2278-344X.1007","volume":"11","author":"SS Bhat","year":"2022","unstructured":"Bhat, S. S., Sindhu, R., & Prasad, S. K. (2022). In silico Screening of Violacein as an epidermal growth factor receptor inhibitor. International Journal of Health & Allied Sciences, 11(1), 39\u201346.","journal-title":"International Journal of Health & Allied Sciences"},{"issue":"2","key":"2095_CR56","doi-asserted-by":"publisher","first-page":"e7808","DOI":"10.1002\/aoc.7808","volume":"39","author":"MN El\u2010Nahass","year":"2025","unstructured":"El\u2010Nahass, M. N., Gaber, M., Elnadry, Y. A., Abu El\u2010Reash, G. M., & El\u2010Gamil, M. M. (2025). Synthesis, structural characterization, optical properties, and biological potency of Co (II), Cu (II), and Cd (II) complexes with heterocyclic thiosemicarbazide ligand: insights from molecular docking studies. Applied Organometallic Chemistry, 39(2), e7808.","journal-title":"Applied Organometallic Chemistry"},{"issue":"4","key":"2095_CR57","doi-asserted-by":"publisher","first-page":"484","DOI":"10.56499\/jppres21.1047_9.4.484","volume":"9","author":"MH Widyananda","year":"2021","unstructured":"Widyananda, M. H., Pratama, S. K., Samoedra, R. S., Sari, F. N., Kharisma, V. D., Ansori, A. N. M., & Antonius, Y. (2021). Molecular docking study of sea urchin (Arbacia lixula) peptides as multi-target inhibitor for non-small cell lung cancer (NSCLC) associated proteins. J Pharm Pharmacogn Res, 9(4), 484\u2013496.","journal-title":"J Pharm Pharmacogn Res"},{"key":"2095_CR58","doi-asserted-by":"publisher","first-page":"117693512110318","DOI":"10.1177\/11769351211031864","volume":"20","author":"TL Wargasetia","year":"2021","unstructured":"Wargasetia, T. L., Ratnawati, H., Widodo, N., & Widyananda, M. H. (2021). Bioinformatics study of sea cucumber peptides as antibreast cancer through inhibiting the activity of overexpressed protein (EGFR, PI3K, AKT1, and CDK4). Cancer Informatics, 20, 11769351211031864.","journal-title":"Cancer Informatics"},{"issue":"10","key":"2095_CR59","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4149\/BLL_2024_93","volume":"125","author":"B Bicak","year":"2024","unstructured":"Bicak, B., & Akman, G. (2024). In silico and in vitro studies of Tyr-Lys-Thr tripeptide against human lung cancer cell line (A549). Bratislava Medical Journal\/Bratislavsk\u00e9 Lek\u00e1rske Listy, 125(10), 597\u2013604.","journal-title":"Bratislava Medical Journal\/Bratislavsk\u00e9 Lek\u00e1rske Listy"},{"issue":"2","key":"2095_CR60","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbrc.2011.02.010","volume":"406","author":"GS Van Aller","year":"2011","unstructured":"Van Aller, G. S., Carson, J. D., Tang, W., Peng, H., Zhao, L., Copeland, R. A., Tummino, P. J., & Luo, L. (2011). Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase\/mTOR inhibitor. Biochemical and Biophysical Research Communications, 406(2), 194\u2013199.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"10","key":"2095_CR61","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/ptr.4888","volume":"27","author":"HY Kim","year":"2013","unstructured":"Kim, H. Y., Jung, S. K., Byun, S., Son, J. E., Oh, M. H., Lee, J., Kang, M. J., Heo, Y. S., Lee, K. W., & Lee, H. J. (2013). Raf and PI3K are the Molecular Targets for the Anti\u2010metastatic Effect of Luteolin. Phytotherapy Research, 27(10), 1481\u20131488.","journal-title":"Phytotherapy Research"},{"issue":"1","key":"2095_CR62","first-page":"11","volume":"1","author":"I Panchal","year":"2021","unstructured":"Panchal, I., Devgirkar, A. G., Patel, A. D., Nagani, A., & Lad, C. (2021). Molecular modelling, synthesis and biological evaluation of novel benzimidazole derivatives for the treatment of breast cancer. Current Chinese. Chemistry, 1(1), 11\u201320.","journal-title":"Chemistry"},{"issue":"4","key":"2095_CR63","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/07391102.2020.1726816","volume":"39","author":"A Kumar","year":"2021","unstructured":"Kumar, A., Rai, S., Rathi, E., Agarwal, P., & Kini, S. G. (2021). Pharmacophore-guided fragment-based design of novel mammalian target of rapamycin inhibitors: extra precision docking, fingerprint-based 2D and atom-based 3D-QSAR modelling. Journal of Biomolecular Structure and Dynamics, 39(4), 1155\u20131173.","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"issue":"3","key":"2095_CR64","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.bmcl.2015.12.075","volume":"26","author":"U Chaube","year":"2016","unstructured":"Chaube, U., Chhatbar, D., & Bhatt, H. (2016). 3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer. Bioorganic & medicinal chemistry letters, 26(3), 864\u2013874.","journal-title":"Bioorganic & medicinal chemistry letters"},{"issue":"3","key":"2095_CR65","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s11030-017-9752-9","volume":"21","author":"U Chaube","year":"2017","unstructured":"Chaube, U., & Bhatt, H. (2017). 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors. Molecular Diversity, 21(3), 741\u2013759.","journal-title":"Molecular Diversity"},{"issue":"9","key":"2095_CR66","doi-asserted-by":"publisher","first-page":"7850","DOI":"10.3390\/ijms24097850","volume":"24","author":"T Vidovic","year":"2023","unstructured":"Vidovic, T., Dakhovnik, A., Hrabovskyi, O., MacArthur, M. R., & Ewald, C. Y. (2023). AI-Predicted mTOR Inhibitor Reduces Cancer Cell Proliferation and Extends the Lifespan of C. elegans. International Journal of Molecular Sciences, 24(9), 7850.","journal-title":"International Journal of Molecular Sciences"},{"key":"2095_CR67","doi-asserted-by":"crossref","unstructured":"Martin Bakht, John Hayward, Farsheed Shahbazi-Raz, et al. Identifying Potential Off-Target Protein Binders of Glutamate-Ureido-Lysine, a Prostate Cancer Specific Imaging Agent. ChemRxiv. 08 October 2020.","DOI":"10.26434\/chemrxiv.13064186.v2"},{"key":"2095_CR68","doi-asserted-by":"publisher","first-page":"128840","DOI":"10.1016\/j.bmcl.2022.128840","volume":"71","author":"NY Zyk","year":"2022","unstructured":"Zyk, N. Y., Ber, A. P., Nimenko, E. A., Shafikov, R. R., Evteev, S. A., Petrov, S. A., Uspenskaya, A. A., Dashkova, N. S., Ivanenkov, Y. A., & Skvortsov, D. A. (2022). Synthesis and initial in vitro evaluation of PSMA-targeting ligands with a modified aromatic moiety at the lysine \u03b5-nitrogen atom. Bioorganic & Medicinal Chemistry Letters, 71, 128840.","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"1","key":"2095_CR69","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00044-022-03002-w","volume":"32","author":"AA Uspenskaya","year":"2023","unstructured":"Uspenskaya, A. A., Nimenko, E. A., Shafikov, R. R., Zyk, N. Y., Evteev, S. A., Dashkova, N. S., Ivanenkov, Y. A., Majouga, A. G., Skvortsov, D. A., & Garanina, A. S. (2023). Optimization of the dipeptide motifs in the PSMA ligands linker structure: synthesis and in vitro evaluation. Medicinal Chemistry Research, 32(1), 32\u201337.","journal-title":"Medicinal Chemistry Research"},{"issue":"1","key":"2095_CR70","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/tox.23981","volume":"39","author":"X Liu","year":"2024","unstructured":"Liu, X., Liu, J., Yan, B., Quan, Z., Wang, X., Ma, Y., Alarfaj, A. A., & Yan, L. (2024). Study of the PI3K\/Akt\/mTOR signaling pathway in vitro and molecular docking analysis of periplocin inhibits cell cycle progression and induces apoptosis in MDA\u2010MB\u2010231. Environmental Toxicology, 39(1), 444\u2013456.","journal-title":"Environmental Toxicology"},{"issue":"1","key":"2095_CR71","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1021\/acsomega.2c04837","volume":"8","author":"S Rathod","year":"2022","unstructured":"Rathod, S., Shinde, K., Porlekar, J., Choudhari, P., Dhavale, R., Mahuli, D., Tamboli, Y., Bhatia, M., Haval, K. P., & Al-Sehemi, A. G. (2022). Computational exploration of anti-cancer potential of flavonoids against cyclin-dependent kinase 8: an in silico molecular docking and dynamic approach. ACS Omega, 8(1), 391\u2013409.","journal-title":"ACS Omega"},{"issue":"11","key":"2095_CR72","doi-asserted-by":"publisher","first-page":"e70591","DOI":"10.1002\/jbt.70591","volume":"39","author":"A Cetin","year":"2025","unstructured":"Cetin, A., Oguz, E., Woli\u0144ska, E., Rozbicki, P., Branowska, D., & T\u00fcrkan, F. (2025). Design, synthesis, and characterization of novel substituted 1, 2, 4\u2010Triazines: cytotoxic activity on HepG2 and HT\u201029 cell lines, enzyme inhibition, and molecular docking studies. Journal of Biochemical and Molecular Toxicology, 39(11), e70591.","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"issue":"4","key":"2095_CR73","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski, C. A. (2004). Lead-and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies, 1(4), 337\u2013341.","journal-title":"Drug Discovery Today: Technologies"},{"issue":"W1","key":"2095_CR74","doi-asserted-by":"publisher","first-page":"W432","DOI":"10.1093\/nar\/gkae298","volume":"52","author":"Y Gu","year":"2024","unstructured":"Gu, Y., Yu, Z., Wang, Y., Chen, L., Lou, C., Yang, C., Li, W., Liu, G., & Tang, Y. (2024). admetSAR3. 0: a comprehensive platform for exploration, prediction and optimization of chemical ADMET properties. Nucleic Acids Research, 52(W1), W432\u2013W438.","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"2095_CR75","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/1389200054021834","volume":"6","author":"Z-Y Zhang","year":"2005","unstructured":"Zhang, Z.-Y., & Wong, Y. N. (2005). Enzyme kinetics for clinically relevant CYP inhibition. Current Drug Metabolism, 6(3), 241\u2013257.","journal-title":"Current Drug Metabolism"},{"issue":"4","key":"2095_CR76","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2174\/138920008784220664","volume":"9","author":"S-F Zhou","year":"2008","unstructured":"Zhou, S.-F. (2008). Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Current Drug Metabolism, 9(4), 310\u2013322.","journal-title":"Current Drug Metabolism"},{"issue":"2","key":"2095_CR77","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/futurepharmacol2020013","volume":"2","author":"PV Zadorozhnii","year":"2022","unstructured":"Zadorozhnii, P. V., Kiselev, V. V., & Kharchenko, A. V. (2022). In silico ADME profiling of salubrinal and its analogues. Future Pharmacology, 2(2), 160\u2013197.","journal-title":"Future Pharmacology"},{"issue":"1","key":"2095_CR78","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0169-409X(02)00171-0","volume":"55","author":"JH Lin","year":"2003","unstructured":"Lin, J. H. (2003). Drug\u2013drug interaction mediated by inhibition and induction of P-glycoprotein. Advanced Drug Delivery Reviews, 55(1), 53\u201381.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"18","key":"2095_CR79","doi-asserted-by":"publisher","first-page":"12403","DOI":"10.1021\/acs.jmedchem.2c01075","volume":"65","author":"L Gebauer","year":"2022","unstructured":"Gebauer, L., Jensen, O., Brockm\u00f6ller, J., & D\u00fccker, C. (2022). Substrates and Inhibitors of the Organic Cation Transporter 3 and Comparison with OCT1 and OCT2. Journal of Medicinal Chemistry, 65(18), 12403\u201312416.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"2095_CR80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.vascn.2013.03.005","volume":"68","author":"D Rampe","year":"2013","unstructured":"Rampe, D., & Brown, A. M. (2013). A history of the role of the hERG channel in cardiac risk assessment. Journal of Pharmacological and Toxicological Methods, 68(1), 13\u201322.","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"2","key":"2095_CR81","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbamem.2007.11.008","volume":"1778","author":"DW Hoskin","year":"2008","unstructured":"Hoskin, D. W., & Ramamoorthy, A. (2008). Studies on anticancer activities of antimicrobial peptides. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1778(2), 357\u2013375.","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"issue":"9","key":"2095_CR82","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1177\/153537020322800903","volume":"228","author":"R Simstein","year":"2003","unstructured":"Simstein, R., Burow, M., Parker, A., Weldon, C., & Beckman, B. (2003). Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Experimental Biology and Medicine, 228(9), 995\u20131003.","journal-title":"Experimental Biology and Medicine"},{"issue":"6","key":"2095_CR83","doi-asserted-by":"publisher","first-page":"e0219180","DOI":"10.1371\/journal.pone.0219180","volume":"14","author":"M Rehan","year":"2019","unstructured":"Rehan, M. (2019). Anticancer compound XL765 as PI3K\/mTOR dual inhibitor: A structural insight into the inhibitory mechanism using computational approaches. PloS one, 14(6), e0219180.","journal-title":"PloS one"},{"issue":"6","key":"2095_CR84","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1080\/10406638.2023.2247117","volume":"44","author":"JT Kilbile","year":"2024","unstructured":"Kilbile, J. T., Tamboli, Y., Ansari, S. A., Rathod, S. S., Choudhari, P. B., Alkahtani, H., & Sapkal, S. B. (2024). Synthesis, biological evaluation, and computational studies of 6-fluoro-3-(piperidin-4-yl)-1, 2-benzisoxazole sulfonamide conjugates. Polycyclic Aromatic Compounds, 44(6), 4157\u20134177.","journal-title":"Polycyclic Aromatic Compounds"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02095-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-026-02095-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02095-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:02:56Z","timestamp":1789635776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-026-02095-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":84,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2095"],"URL":"https:\/\/doi.org\/10.1007\/s12013-026-02095-z","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}